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Nocturnal desaturationAbstract The effects of sleep-disordered breathing (SDB) and nocturnal hypoxemia on pulmonary
hemodynamics have long interested physicians who manage patients with pulmonary arterial
hypertension. The aim of the present study is to study the prevalence and identify the types of sleep
related breathing disorders in patients with IPAH in the state of Kuwait.
Patients and methods: 36 patients(32 females and 4 males) were included, the mean age was
35.2 ± 17.3 years, all patients were non-smokers and non-obese. All patients were subjected to
routine investigations, Echocardiography, CT pulmonary angiography and full night polysomno-
graphy. All cases pulmonary hypertension related to cardiac disease or collagenic vascular disease
or Thromboembolic disease were excluded.
Results: The mean AHI was 13.8 ± 8.3/h of sleep with OSA proved in 5 patients (13.9%) and
CSR/CSA proved in 2 patients (5.56%). Nocturnal desaturation was more pronounced in the stud-
ied patient as 27 patients (75%) showed nocturnal desaturation. There was a signiﬁcant correlation
between SDB measures and baseline oxygen saturation, lowest oxygen saturation during walking
and mean PAP.
Conclusion: SDB is signiﬁcant in patients with IPAH and can affect the disease progression and
the quality of life of those patients. All patients should undergo sleep study to identify patients who
are in need of nocturnal oxygen therapy or in need for CPAP therapy in case of OSA.
 2015 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Pulmonary hypertension (PH) is deﬁned by a mean pulmonary
artery pressure P25 mm Hg at rest, measured during right
heart catheterization. There is still insufﬁcient evidence to add
an exercise criterion to this deﬁnition [1]. The term pulmonary
arterial hypertension (PAH) describes a subpopulation of
234 H. Shaarawy, A. Elhawarypatients with PH characterized hemodynamically by the
presence of pre-capillary PH including an end-expiratory
pulmonary artery wedge pressure (PAWP) 615 mm Hg and
a pulmonary vascular resistance >3 Wood units. Right heart
catheterization remains essential for a diagnosis of PH or
PAH [2,3].
Primary pulmonary hypertension (PPH) is a rare disease
characterized by elevated pulmonary artery pressure with no
apparent cause. PPH is also termed precapillary pulmonary
hypertension or, as is currently preferred, idiopathic
pulmonary arterial hypertension (IPAH) [4].
The effects of sleep-disordered breathing (SDB) and noc-
turnal hypoxemia on pulmonary hemodynamics have long
interested physicians who manage patients with pulmonary
arterial hypertension (PAH). SDB, a term that encompasses
the spectrum of Cheyne-Stokes respiration/central sleep apnea
(CSR/CSA), obstructive sleep apnea (OSA) and nocturnal
desaturation, is a common condition in the United States
and western nations [5].
Sleep causes a profound effect in individuals with severe
pulmonary disease, by its inﬂuence on the respiratory drive,
airway stability, and ventilatory mechanics [6,7]. Reported
sleep disturbances in patients with pulmonary disease include
unsuspected obstructive sleep apnea and a high prevalence of
insomnia, excessive daytime sleepiness, and nightmares com-
pared to the general population, in addition, patients with
COPD, kyphoscoliosis, and neuromuscular disorders have
been shown to frequently desaturate, especially during rapid
eye movement (REM) sleep [8–10]. Nocturnal hypoxemia
can lead to polycythemia, respiratory failure, and pulmonary
hypertension. Hypoxemia causes pulmonary vasoconstriction
and elevated pulmonary artery pressures. In patients with
PPH, untreated and unsuspected nocturnal hypoxemia can
have deleterious effects and may worsen the pulmonary
hypertension.Aim of the work
The aim of the present study was to study the prevalence and
identify the types of sleep related breathing disorders in
patients with IPAH in the state of Kuwait.Patients and methods
This study was carried out at the Pulmonary Rehabilitation
Center – Pulmonary Hypertension Unit which is the only spe-
cialized unit to mange IPAH patients in the Ministry of
Health, state of Kuwait.
The study was a retrospective study including all patients
with IPAH seen in the unit in the last 6 years from Jan 2009
to Dec 2014 and still under follow up in the outpatient clinic.
Study was approved by the ethics committee in the MOI, state
of Kuwait.
This study was performed on (36) 1PH patients (4) males
and (32) females with age ranging from 18 to 65 years.
Inclusion criteria
Adult patients proved to have IPAH without any co-morbidity
at the time of diagnosis.Exclusion criteria
– Patients with BMI >35.
– Patient with COPD or chronic lung disease.
– Patient with Connective tissue diseases.
– Patient with Thromboembolic disease.
– Patients with PH secondary to heart disease or patients with
congestive heart failure.
– Patients already diagnosed with SDB or on long term
oxygen therapy.
 PEulmonary hypertension was conﬁrmed by right heart
catheterization and was deﬁned as a mean pulmonary
artery pressure of >25 mm Hg at rest or >30 mm Hg
during exercise [4].
 Functional class was estimated according to New York
Heart Association (NYHA) classiﬁcation [11].
To diagnose IPH, secondary causes of pulmonary hypertension
were ruled out in all patients by
– Full history taking with stress on: chest symptoms, special
habits especially smoking, cardiac symptoms.
– Physical examinations.
– Chest radiographs.
– High-resolution CT scans and CT pulmonary angiography.
– Pulmonary function studies.
– Transthoracic echocardiograms and transesophageal
echocardiograms.
– Ventilation–perfusion scans.
– Right and left heart catheterization.
– Screening for connective tissue diseases.
For evaluation of sleep related breathing disorders patients were
subjected to
– Thorough history taking about sleep symptoms.
– Physical examinations with stress on: Neck circumference.
– Body mass index (BMI). Calculation of Body mass index
(BMI): The used method for estimation of the body mass
index was the weight–height index according to the follow-
ing equation [12].
– BMI = weight (kg)/height2 (m2).
– Epworth sleepiness scale (ESS) [13].
– Arterial blood gases.
– The 6-min walk test [14].
– Oxygen saturation by pulse oximetry (SpO2) was measured
at rest and during ambulation.
– Polysomnography (PSG): Full night polysomnography
involving the recording of electroencephalography (EEG)
electro-oculography (EOG), submental and anterior tibial
electromyography (EMG), electrocardiography (ECG), res-
piratory effort (abdominal and thoracic effort), nasal air-
ﬂow sensor and oxygen saturation (pulse oximetry) and
position detection camera. Polysomnography used in this
study is a full night polysomnography (Alice 4 Respironics),
according to polysomnography OSA was diagnosed if the
Apnea/Hypopnea index (AHI) is more than 5/h of sleep
with more than 50% of all apneas occurring during sleep
are of obstructive nature, CSR/CSA was diagnosed if there
Table 2 Polysomnography data of the patients.
Character Mean ± SD
Total sleep time (TST) in min. 358.1 ± 3.5
Sleep eﬃciency 72.4 ± 3.25
Non REM sleep time as % from TST 75.3 ± 6.8
REM sleep time as % from TST 20.4 ± 2.9
Arousal index/h 23.5 ± 7.9
AHI/h 13.8 ± 8.3
No. of OSA patients 5/36 (13.9%)
No. of CSR/CSA patients 2/36 (5.56%)
Lowest SaO2 during sleep 77.2 ± 11.3
D90 as % from TST 28.6 ± 9.4
Oxygen desaturation index 4% 23.6 ± 6.5
No. of patients with nocturnal desaturation 27/36 (75%)
REM: Rapid Eye Movement, AHI: Apnea/Hypopnea Index.
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apnea associated with the absence of thoracic or abdominal
movements and attack lasting for more than 10 sec and the
patient is diagnosed as having morbid CSA if attacks are
more than 10/h of sleep, nocturnal desaturation was diag-
nosed if the oxygen desaturation index 4% (ODI 4%) was
more than 10/h of sleep (it means that the oxygen satura-
tion drops by more than 4% from the baseline) associated
with the time of sleep spent with oxygen saturation
<90% (D90) equals to 10% or more from the total sleep
time [15].
Statistical analysis
All statistical analyses were conducted using the software
package SPSS 20.0 for Windows (SPSS Inc., Chicago, IL,
USA). All data are tabulated and presented as mean ± stan-
dard deviation. Spearman’s correlation was done to correlate
between the polysomnography data and the general and
ECHO data of the patients. Signiﬁcant results were detected
at p< 0.05.
Results
Table 1 shows that the number of patients included in the
study was 36 patients, and the mean age was 35.2 ±
17.3 years, 32 females and 4 males. All patients were non
smokers, non obese (the mean BMI was 24.2 ± 6.3, ESS was
less than 10 in all patients denoting no signiﬁcant signs of
day time sleepiness (mean was 6.1 ± 2.8). The mean six minute
walking distance for the patients was 368.2 ± 105.9 m with
base line SaO2 was 93.6 ± 5.4% during wakefulness and the
lowest SaO2 reached during walking was 82.6 ± 11.1%. As
regards the PFTs of the studied patients the mean FEV1%Table 1 General criteria of the patients.
Character Mean ± SD
No. of patients 36
Age in years 35.2 ± 17.3
Smoking status 0/36
Female/male ratio 32/4
Body mass index (Kg/m2) 24.2 ± 6.3
Epworth Sleepiness Scale (ESS) 6.1 ± 2.8
Six minute walking distance in m 368.2 ± 105.9
Base line SaO2 during wakefulness 93.6 ± 5.4
Lowest SaO2 during walking 82.6 ± 11.1
PFT
FEV1% pred. 78.3 ± 3.64
FVC% pred. 73.6 ± 6.5
FEV1/FVC 83.4 ± 2.3
FEF25–75% pred. 62.3 ± 6.8





Mean PA pressure in mm Hg 48.4 ± 12.9
Cardiac index L/min/m2 3.2 ± 0.5pred. was 78.3 ± 3.64, mean FVC% pred. was 73.6 ± 6.5
while the mean FEV1/FVC was 83.4 ± 2.3 denoting the pres-
ence of mild restrictive pattern in the studied patients with no
signs of airway obstruction. On the other hand the mean
FEF25–75% pred. was 62.3 ± 6.8 denoting small airway dis-
ease. As regards the NYHA class there were 2 patients in class
1, 24 patients in class 2 and 10 patients were in class 3. None of
the studied patients were in class 4. Lastly the mean PAP of the
studied patients was 48.4 ± 12.9 mm Hg and the cardiac index
was 3.2 ± 0.5 L/min/m2.
Table 2 shows that the TST of the studied patient was
358.1 ± 3.5 minutes with sleep efﬁciency of 72.4 ± 3.25%.
The percentage of non REM sleep from the TST was
75.3 ± 6.8%, while the percentage of REM sleep from the
TST was 20.4 ± 2.9%. The mean arousal index during sleep
was markedly increased denoting disturbed sleep in these
patients (23.5 ± 7.9/h) which can affect the quality of life. As
regard measures of SDB the total AHI during sleep was
13.8 ± 8.3/h which is bigger than normal in comparison to
the general population with the no. of OSA patients was 5
patients, all were females (13.9%) denoting increased incidence
of OSA in this group of patients more than in the general pop-
ulation. The no. of CSR/CSA patient was 2 (5.56%) and these 2
patients were in NYHA class 3. As regards the measures of
nocturnal desaturation the lowest oxygen saturation reached
during sleep was 77.2 ± 11.3%, mean ODI4% was
23.6 ± 6.5/h of sleep and the mean D90 was 28.6 ± 9.4% from
the TST. According to the deﬁnition of nocturnal desaturation
stated above the no. of nocturnal desaturators in this study was
27 patients (75%) denoting a signiﬁcant prevalence of this phe-
nomena in these patients with its consequences on the disease
and the negative effect on the quality of life in these patients.
On using Spearman’s correlation coefﬁcient (Table 3), there
was a signiﬁcant correlation between the baseline oxygen satu-
ration during rest and all parameters of nocturnal desaturation
including the lowest oxygen saturation reached during sleep
(p= 0.003), D90 (p= 0.006) and the ODI4% (p= 0.04), also
the baseline oxygen saturation during rest showed a signiﬁcant
correlation with the arousal index during sleep (p= 0.04). On
the other hand the lowest oxygen saturation reached during
walking showed a signiﬁcant correlation with the Lowest
SaO2 during sleep (p= 0.005), D90 (p= 0.004) and the
arousal index (p= 0.03). The mean PAP showed a signiﬁcant
correlation with D90 (p= 0.005), the AHI (p= 0.04) and the
Table 3 Positive correlations detected between the general
criteria and polysomnography criteria of the patients.
General criteria Polysomnography criteria P value




Lowest SaO2 during exercise Lowest SaO2 during sleep 0.005
D90 0.004
Arousal index 0.03
Mean PAP D90 0.005
AHI 0.04
Arousal index 0.03
D90: time spent with oxygen saturation below 90% as percentage
from total sleep time, ODI4%: oxygen desaturation index/h of
sleep, PAP: Pulmonary Artery Pressure.
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ESS or any of the parameters of pulmonary function testing did
not show any signiﬁcant correlation with the AHI or any of the
parameters of nocturnal desaturation in the studied patients.
Discussion
The aim of the present study was to estimate the prevalence and
deﬁne the different types of sleep disordered breathing in
patients with Idiopathic PAH. The most encountered type of
SDB observed was the nocturnal desaturation which was pre-
sent in 27 patients (75%). Nocturnal desaturation was present
irrespective of the presence of any other event like hypopnea or
apnea giving the possibility of V/Q mismatch as a reasonable
explanation. This abnormality is well known in patients with
PAH and its cause is not only due to obliteration of small pul-
monary arterioles which increases pulmonary physiologic dead
space, but also to narrowed distal airways [16–18]. In this ﬁeld
it is worth noting that the FEF25–75 was decreased (62.3 ±
6.8% pred.) denoting the small airways were affected but
FEF25–75 did not show any correlation to the parameters of
SDB in the present study. On the other hand nocturnal desatu-
ration was correlated with baseline oxygen saturation at rest,
lowest oxygen saturation reached during walking and mean
PAP. As regard the AHI it was elevated in this group of
patients (13.8 ± 8.3/h of sleep) with 5 female cases proved to
have OSA (13.9% of all cases and 15.6% from female patients
alone) which is more than estimated for the general population
in which the incidence is in the range of 9% for adult females
[5], these patient were not obese and did not complain of day
time sleepiness denoting the importance of doing sleep study
in such group of patients to uncover the hidden OSA which
can add to the poor prognosis of these patients. Changes in ven-
tilation during sleep, such as mild hypoventilation, [19,20]
decreased functional residual capacity, [21] blunted responses
to hypoxemia and hypercapnia, [22] and increased upper air-
way resistance, are well established [23]. Such ventilatory
changes are mild and well tolerated in healthy individuals but
may exhibit more profound gas exchange abnormalities in
patients with PAH; the presence of nocturnal desaturation or
OSA in these patients will cause pulmonary vasoconstrictionwhich is a direct response to alveolar hypoxia in a physiologic
attempt to minimize ventilation perfusion mismatch. The recur-
rence of hypoxemic episodes in sleep apnea results in repetitive
increases in pulmonary artery pressures; however, about 1 in 5
patients develop sustained pulmonary hypertension during the
daytime [24]. More severe OSA and hypoxia may lead to right
ventricular hypertrophy culminating in daytime pulmonary
hypertension and right ventricular failure in the presence of
hypercapnia and chronic alveolar hypoventilation [25].
Although the idea of the present study is not new it adds more
information and evidence about the presence of SDB in
patients with IPAH which is a rare disease and at the same time
it is one of the few studies done in the middle east in this ﬁeld;
the results of the present study are in agreement with the result
of many researchers, who worked in the same ﬁeld. Rafanan in
2001 [26] studied 13 patients with IPAH through single night
full polysomnography and found that Seventy-seven percent
of patients with IPAH have signiﬁcant nocturnal hypoxemia
that is unrelated to apneas and hypopneas. Nocturnal desatura-
tion occurs more frequently in patients with higher P (A–a) O2
values and lower FEV1 values, resting arterial PaO2 and SpO2
values, and walking SpO2 values. Schulz in 2002 [27] investi-
gated the presence of periodic breathing in 20 patients with
IPAH by pulmonary function testing, right heart catheteriza-
tion and full night polysomnography, they found that Periodic
breathing occurs in patients with advanced primary pulmonary
hypertension and can be reversed by nocturnal nasal oxygen.
The clinical and prognostic signiﬁcance of periodic breathing
in primary pulmonary hypertension needs to be determined
by further studies. It is worth noting that in the present study
there were 2 patients suffering from CSR/CSA and the 2
patients were belonging to NYHA class 3, so the presence of
CSR/CSA in these 2 patients was possibly attributed to have
an effect on the cardiac condition. Ulrich in 2008 [28] studied
38 patients with pulmonary hypertension (23 patients with
IPAH and 15 patients with chronic Thromboembolic disease)
with full night polysomnography and ambulatory cardio-
respiratory studies. They concluded that in patients with pul-
monary hypertension, CSR/CSA is common, but obstructive
sleep apnea also occurs. Sleep-related breathing disorders are
not associated with excessive sleepiness but affect the quality
of life. They should be evaluated by polysomnography or car-
diorespiratory sleep studies because pulse oximetry may fail
to detect signiﬁcant sleep apnea. Prisco in 2011 [29] studied
the Correlation of pulmonary hypertension severity with met-
rics of comorbid sleep-disordered breathing. The study
included 28 patients with pulmonary hypertension (32% of
idiopathic origin and 68% associated with other diseases). They
concluded that SDB comprising obstructive apneas, hypop-
neas, and nocturnal hypoxemia is prevalent in PH and cannot
be accurately predicted by sleep apnea signs and symptoms or
diurnal rest and exercise SaO2. The association of AHI and
T90% with mPAP suggests a potential relationship between
the pathophysiology of sleep-disordered breathing and PH.
Jilwan in 2013 [30] studied 46 patients with pulmonary
hypertension (29 patients with IPAH and 17 patients with
Thromboembolic disease) with full night polysomnography
and trans-cutaneous capnography. They found that nocturnal
desaturation was present in 82.6% of patients with pulmonary
hypertension with the main mechanism of V/Q mismatch either
alone or in association with obstructive events as Apnea or
Hypopnea, and the mean PAP not the clinical symptoms was
Study of sleep related respiratory disorders 237predictive of nocturnal desaturation. They concluded that the
occurrence of nocturnal hypoxemia is high in PH and should
be screened for systematically. Further studies are needed to
determine the impact of nocturnal hypoxemia on the outcome
of patients with PH.
Conclusion
SDB is signiﬁcant in patients with IPAH and can affect the dis-
ease progression and the quality of life of those patients. All
patients should undergo sleep study to identify patients who
are in need of nocturnal oxygen therapy or in need for CPAP
therapy in case of OSA.
Conflict of interest
There is no conﬂict of interest.
References
[1] G. Simonneau, M.A. Gatzoulis, I. Adatia, D. Celermajer, C.
Denton, A. Ghofrani, et al, Updated clinical classiﬁcation of
pulmonary hypertension, J. Am. Coll. Cardiol. 62 (25 Suppl)
(2013) D34–41.
[2] M. McGoon, D. Gutterman, V. Steen, et al, Screening, early
detection, and diagnosis of pulmonary arterial hypertension:
ACCP evidence-based clinical practice guidelines, Chest 126 (1
Suppl) (2004) 14S–34S.
[3] R.J. Barst, M. McGoon, A. Torbicki, Diagnosis and differential
assessment of pulmonary arterial hypertension, J. Am. Coll.
Cardiol. 43 (2004) 40S–47S, 12 Suppl S.
[4] V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W.
Farber, J.R. Lindner, et al, ACCF/AHA 2009 expert consensus
document on pulmonary hypertension: a report of the American
College of Cardiology Foundation Task Force on Expert
Consensus Documents and the American Heart Association:
developed in collaboration with the American College of Chest
Physicians, American Thoracic Society Inc, and the Pulmonary
Hypertension Association, Circulation 119 (16) (2009) 2250–
2294.
[5] T. Young, M. Palta, J. Dempsey, et al, The occurrence of sleep-
disordered breathing among middle-aged adults, N. Engl. J.
Med. 328 (1993) 1230–1235.
[6] N.J. Douglas, Control of ventilation during sleep, Clin. Chest
Med. 6 (4) (1985) 563–575.
[7] J.R. Stradling, G.A. Chadwick, A.J. Frew, Change in ventilation
and its components in normal subjects during sleep, Thorax 40
(5) (1985) 364–370.
[8] S. Sourour, S. Hafez, S. Atta, M. Mahmoud, H. Shaarawy,
Study of sleep related respiratory disorders in patients with
stable COPD. (MS thesis). Faculty of Medicine, Alex
University, 2000.
[9] E.H. Sawicka, M.A. Branthwalte, Respiration during sleep in
kyphoscoliosis, Thorax 42 (1987) 801–808.
[10] S.C. Bourke, G.J. Gibson, Sleep and breathing in
neuromuscular diseases, ERJ 19 (6) (2002) 1194–1201.
[11] The Criteria Committee of the New York Heart Association.
(1994). Nomenclature and Criteria for Diagnosis of Diseases ofthe Heart and Great Vessels. (9th ed.). Boston: Little, Brown &
Co. pp. 253–256.
[12] E. Jequire, Energy, obesity and body weight standards, Am. J.
Clin. Nutr. 45 (1987) 1035–1047.
[13] M.W. Johns, A new method for measuring daytime sleepiness:
the Epworth sleepiness scale, Sleep 14 (1991) 540–545.
[14] Function ATSCoPSfCP, ATS statement: guidelines for the six-
minute walk test, Am. J. Respir. Crit. Care Med. 166 (1) (2002)
111–117.
[15] Sleep related breathing disorders in adults: recommendations for
syndrome deﬁnition and measurement techniques in clinical
research. The Report of the American Academy of Sleep
Medicine Task Force. Sleep 1999; 22 : 667–689.
[16] Z.C. Jing, X.Q. Xu, D.B. Badesch, et al, Pulmonary function
testing in patients with pulmonary arterial hypertension, Respir.
Med. 103 (8) (2009) 1136–1142.
[17] F.J. Meyer, R. Ewert, M.M. Hoeper, et al, German PPH Study
Group. Peripheral airway obstruction in primary pulmonary
hypertension, Thorax 57 (6) (2002) 473–476.
[18] X.G. Sun, J.E. Hansen, R.J. Oudiz, K. Wasserman, Pulmonary
function in primary pulmonary hypertension, J. Am. Coll.
Cardiol. 41 (6) (2003) 1028–1035.
[19] N.J. Douglas, D.P. White, C.K. Pickett, J.V. Weil, C.W.
Zwillich, Respiration during sleep in normal man, Thorax 37
(11) (1982) 840–844.
[20] E.D. Robin, R.D. Whaley, C.H. Crump, D.M. Travis, Alveolar
gas tensions, pulmonary ventilation and blood pH during
physiologic sleep in normal subjects, J. Clin. Invest. 37 (7)
(1958) 981–989.
[21] D.W. Hudgel, P. Devadatta, Decrease in functional residual
capacity during sleep in normal humans, J. Appl. Physiol. 57 (5)
(1984) 1319–1322.
[22] N.J. Douglas, D.P. White, J.V. Weil, C.K. Pickett, R.J. Martin,
D.W. Hudgel, Hypoxic ventilatory response decreases during
sleep in normal men, Am. Rev. Respir. Dis. 125 (3) (1982) 286–
289.
[23] D.W. Hudgel, R.J. Martin, B. Johnson, P. Hill, Mechanics of
the respiratory system and breathing pattern during sleep in
normal humans, J. Appl. Physiol. 56 (1) (1984) 133–137.
[24] K.D. O’Halloran, A. Bradford, The pathophysiology of sleep
apnoea: what we have learned from animal models of chronic
intermittent hypoxia, Curr. Respir. Med. Rev. 3 (1) (2007) 19–
27.
[25] A. Foucher, Cardiovascular consequences of sleep apnea,
Nephrol. Ther. 3 (7) (2007) 463–473.
[26] A.L. Rafanan, J.A. Golish, D.S. Dinner, L.K. Hague, A.C.
Arroliga, Nocturnal hypoxemia is common in primary
pulmonary hypertension, Chest 120 (3) (2001) 894–899.
[27] R. Schulz, G. Baseler, H.A. Ghofrani, F. Grimminger, H.
Olschewski, W. Seeger, Nocturnal periodic breathing in primary
pulmonary hypertension, Eur. Respir. J. 19 (4) (2002) 658–663.
[28] S. Ulrich, M. Fischler, R. Speich, K.E. Bloch, Sleep-related
breathing disorders in patients with pulmonary hypertension,
Chest 133 (6) (2008) 1375–1380.
[29] D.L. Prisco, A.L. Sica, A. Talwar, et al, Correlation of
pulmonary hypertension severity with metrics of comorbid
sleep disordered breathing, Sleep Breath 15 (4) (2011) 633–639.
[30] F.N. Jilwan, P. Escourrou, G. Garcia, X. Jaı¨s, M. Humbert, G.
Roisman, High occurrence of hypoxemic sleep respiratory
disorders in precapillary pulmonary hypertension and
mechanisms, Chest 143 (1) (2013) 47–55.
